Company Filing History:
Years Active: 2017-2018
Title: Maho Kondo: Innovator in Dysphagia Treatment
Introduction
Maho Kondo is a prominent inventor based in Kanagawa, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of dysphagia. With a total of 3 patents to her name, Kondo is recognized for her innovative approaches to improving patient care.
Latest Patents
Kondo's latest patents focus on local administration-type pharmaceuticals aimed at improving dysphagia. One of her notable inventions is a dysphagia improving composition characterized by the administration of a substance that inhibits angiotensin converting enzyme, which is known to degrade substance P. This composition is designed to be administered locally in a dosage that does not influence blood pressure. Another patent also revolves around a pharmaceutical for improving dysphagia, emphasizing the same innovative composition.
Career Highlights
Maho Kondo is currently associated with Meiji Seika Pharma Co., Ltd., where she continues to develop groundbreaking solutions for dysphagia. Her work is pivotal in enhancing the quality of life for individuals suffering from this condition.
Collaborations
Kondo collaborates with esteemed colleagues such as Koichi Kitamura and Kiyoshi Shimoyama, contributing to a dynamic research environment that fosters innovation.
Conclusion
Maho Kondo's contributions to dysphagia treatment through her patents and collaborations highlight her role as a leading inventor in the pharmaceutical industry. Her work continues to pave the way for advancements in patient care.